RecruitingNot ApplicableNCT05991453

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial


Sponsor

Washington University School of Medicine

Enrollment

13,000 participants

Start Date

Sep 13, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators will conduct a 13,000-patient randomized multi-center trial to determine (i) which general anesthesia technique yields superior patient recovery experiences in any of three surgical categories ((a) major inpatient surgery, (b) minor inpatient surgery, (c) outpatient surgery) and (ii) whether TIVA confers no more than a small (0.2 %) increased risk of intraoperative awareness than INVA in patients undergoing both outpatient and inpatient surgeries


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Each patient must meet all of the following criteria:
  • Aged 18 years or older
  • Undergoing elective non-cardiac surgery expected to last ≥ 60 min requiring general anesthesia with a tracheal tube or laryngeal mask airway (or similar supra-glottic device)

Exclusion Criteria10

  • Patients will not be enrolled if any of the following criteria are met:
  • Inability to provide informed consent in English (at all study sites) or Spanish (at sites where Spanish consent is provided as an option)
  • Pregnancy (based on patient report or positive test on the day of surgery)
  • Surgical procedure requiring general, regional, neuraxial anesthesia administered by an anesthesia clinician (anesthesiologist, CRNA, anesthesiology assistant) occurring within 30 days prior to or planned to occur within 30 days after surgery date
  • Contraindication to propofol TIVA or INVA (for example, documented allergy to propofol, history of severe postoperative nausea or vomiting, concern for or history of malignant hyperthermia) based on self-report
  • Surgical procedures requiring a specific general anesthesia technique (for example, TIVA required for neuromonitoring).
  • Locally approved, written protocol mandating a particular anesthetic technique
  • History of possible or definite intraoperative awareness during general anesthesia based on patient self-report
  • Planned postoperative intubation
  • Current incarceration

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAnesthetic technique Propofol TIVA

Propofol TIVA no inhaled agent

OTHERAnesthetic technique inhaled agent

Must administer inhaled agent.


Locations(20)

University of Arkansas for Medical Sciences (UAMS)

Little Rock, Arkansas, United States

University of California San Francisco

San Francisco, California, United States

Stanford University

Stanford, California, United States

Yale School of Medicine

New Haven, Connecticut, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

Brigham & Women's

Boston, Massachusetts, United States

University of Michigan

Ann Arbor, Michigan, United States

Henry Ford Health

Detroit, Michigan, United States

Washington University School of Medicine

St Louis, Missouri, United States

Dartmouth Hitchcock Medical Center

Lebanon, New Hampshire, United States

NYU Langone

New York, New York, United States

Weill Cornell Medicine

New York, New York, United States

Duke University

Durham, North Carolina, United States

Wake Forest

Winston-Salem, North Carolina, United States

Oregon Health and Sciences University

Portland, Oregon, United States

University of Pennsylvania

Philadelphia, Pennsylvania, United States

University of Texas - MD Anderson

Houston, Texas, United States

University of Utah - Medical

Salt Lake City, Utah, United States

UVA Health

Charlottesville, Virginia, United States

University of Washington

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05991453


Related Trials